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The adaptor protein missing-in-metastasis
(MIM) contains independent F- and G-actin
binding domains, consisting, respectively, of
an N-terminal 250 aa IRSp53/MIM homology
domain (IMD) and a C-terminal WASP-homol-
ogy domain 2 (WH2). We determined the crystal
structures of MIM’s IMD and that of its WH2
bound to actin. The IMD forms a dimer, with
each subunit folded as an antiparallel three-
helix bundle. This fold is related to that of the
BAR domain. Like the BAR domain, the IMD
has been implicated in membrane binding.
Yet, comparison of the structures reveals that
the membrane binding surfaces of the two
domains have opposite curvatures, which may
determine the type of curvature of the interact-
ing membrane. The WH2 of MIM is longer than
the prototypical WH2, interacting with all four
subdomains of actin. We characterize a similar
WH2 at the C terminus of IRSp53 and propose
that in these two proteins WH2 performs a
scaffolding function.
INTRODUCTION
Missing-in-metastasis (MIM) and insulin receptor tyrosine
kinase substrate p53 (IRSp53) form part of a new family
of actin cytoskeleton adaptor proteins (Bompard et al.,
2005; Funato et al., 2004; Miki et al., 2000; Woodings
et al., 2003). Like most actin binding proteins, MIM and
IRSp53 are multidomain proteins, containing protein-
protein interaction modules, involved in signaling and lo-
calization, and structurally conserved actin binding motifs.
A gene coding for a 356 aa C-terminal fragment of MIM
was originally isolated using mRNA differential display,
and this fragment was identified as a protein whose
expression appeared to be downregulated in certain
bladder cancer cell lines (Lee et al., 2002). Full-length
MIM was subsequently cloned and shown to containStructure 15, 145–759 aa (Woodings et al., 2003). Although it was initially
proposed that MIM might function as a metastasis sup-
pressor protein (Lee et al., 2002), this role has not been
confirmed (Bompard et al., 2005; Nixdorf et al., 2004). In-
stead, MIM seems to play a role in cytoskeleton remodel-
ing (Lin et al., 2005; Mattila et al., 2003; Yamagishi et al.,
2004), possibly downstream of tyrosine kinase signaling
(Gonzalez-Quevedo et al., 2005; Woodings et al., 2003)
and Rho-family GTPases (Bompard et al., 2005). MIM
localizes to areas of dynamic actin assembly, and its over-
expression induces the formation of actin-rich protrusions
resembling surface ruffles and microspikes (Woodings
et al., 2003). MIM has also been identified as a sonic
hedgehog inducible protein that potentiates Gli transcrip-
tion (Callahan et al., 2004).
MIM is a modular protein (Figure 1A). Its actin binding
function can be attributed to two spatially separated
actin-binding domains: an N-terminal 250 aa IRSp53/
MIM homology domain (IMD) (Yamagishi et al., 2004)
and a C-terminal 30 aa WASP-homology domain 2
(WH2) (Mattila et al., 2003). The 475 aa central region
sandwiched in between these two actin-binding domains
is rich in Pro, Ser, and Thr residues. This region appears to
play regulatory/scaffolding roles; it binds receptor protein
tyrosine phosphatase d (RPTPd) (Gonzalez-Quevedo
et al., 2005; Woodings et al., 2003), the transcription factor
Gli and the tumor suppressor Sufu (Callahan et al., 2004),
and the SH3 domain of cortactin (Lin et al., 2005), a protein
implicated in the nucleation and stabilization of Arp2/3-
mediated filament branches (Uruno et al., 2001; Weaver
et al., 2001).
The relationship between MIM and IRSp53 first
emerged from the discovery that the two proteins share
similar N-terminal IMDs, an actin-binding domain that
has also been implicated in actin bundling (Yamagishi
et al., 2004). Like MIM, IRSp53 is an adaptor protein that
plays a role in actin cytoskeleton remodeling by linking
Rho-family GTPases, such as Rac and Cdc42, to effector
proteins, such as Mena (Krugmann et al., 2001) and the
Arp2/3 complex activator protein WAVE (Miki et al.,
2000). The crystal structure of the IMD of IRSp53 has
been determined, consisting of a dimer, with each subunit
forming an extended four-helix bundle (Millard et al., 2005).155, February 2007 ª2007 Elsevier Ltd All rights reserved 145
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Actin-Binding Domain of Missing-in-MetastasisFigure 1. Crystal Structure of the IMD of Mouse MIM
(A) Schematic representation of MIM (yellow/blue, IMD; purple, middle regulatory/scaffolding region; red, WH2).
(B) Ribbon representation of the structure of the IMD dimer (figure made with the program PyMOL, http://www.pymol.org). The two subunit of the
dimer are colored blue and yellow. Helices 1 to 3 of each subunit are labeled H1, H2, and H3. Also shown is a sequence alignment corresponding
to the conserved basic cluster at the symmetric ends of the IMD dimer (highlighted cyan in one of the subunits of the structure). In this alignment,
red, blue, and green represent negatively charged, positively charged, and hydrophobic conserved amino acids, respectively. Accession numbers
are: MIM_MOUSE, Q8R1S4; MIM_HUMAN, O43312; ABBA_HUMAN, Q765P7; IRSp53_HUMAN, Q9UQB8. Red arrows point to amino acids Leu 145
and Leu 147, which were mutated in this study.
(C) Slice cut through the middle of the molecular surface of the IMD dimer revealing the interior cavity.
(D) Close-up view of the ‘‘flap’’ loop between helices 3 and 4 that covers the ‘‘signature sequence’’ (Yamagishi et al., 2004) of the IMD, which is
a charged and conserved sequence that is buried in the structure (red colored area of helix 3).
(E) Superimposition of the structures of the IMDs of MIM and IRSp53. The two structures were superimposed based on the best overlapping central
region (amino acids 26–68, 72–110 and 24–66, 69–107 of both chains of MIM and IRSp53, respectively). The view is as in (B) and Figure 3. This ori-
entation highlights the differences between the A chains of the two proteins (blue). Although not well seen from this angle, similar differences occur
between the B chains (yellow). Notice that helix 4 of the IMD of IRSp53 is missing in MIM.Here we describe the crystal structures of the IMD of
MIM and that of its WH2 bound to actin. Despite low
sequence similarity, the IMDs of MIM and IRSp53 are
structurally similar and, therefore, may bind actin and
Rac in a similar fashion. The structure of the IMD is gener-
ally related to that of the BAR (Bin-Amphiphysin-Rvs)
domain, a fold involved in membrane binding (Peter146 Structure 15, 145–155, February 2007 ª2007 Elsevier Ltd Alet al., 2004). However, the overall shape of the two
domains is markedly different, which probably explains
their different roles in membrane curvature sensing. The
WH2 of MIM is unusual, both because of its localization
in the protein and the way in which it interacts with actin.
We characterize a similar WH2 in IRSp53, further expand-
ing the relationship between these two adaptor proteins.l rights reserved
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Actin-Binding Domain of Missing-in-MetastasisTable 1. Crystallographic Data and Refinement Statistics
IMD
WH2 High-Resolution Se-Peak
Diffraction Statistics
Space group P 21 21 21 P 21 P 21
Cell parameters
a, b, c (A˚) 42.1, 75.5, 229.0 53.5, 37.3, 129.0 53.5, 37.3, 128.9
a, b, g () 90.0, 90.0, 90.0 90.0, 94.07, 90.0 90.0, 94.08, 90.0
Resolution
Total (A˚) 41.4–2.5 48–1.85 48–2.1
Highest shell (A˚) 2.59–2.5 1.92–1.85 2.17–2.1
Completeness (%) 88.7 (80.1) 98.7 (86.7) 99.4 (99.1)
Redundancy 8.9 (5.1) 10.7 (4.5) 6.8 (6.5)
Unique reflections 23,589 (2,069) 43,479 (3,873) 30,686 (3,335)
R mergea (%) 7.2 (23.2) 5.7 (38) 8.6 (33.3)
Average I/s 25.8 (7.2) 30.4 (3.6) 11.8 (3.5)
Refinement Statistics
R factorb (%) 21.7 18.4
R freec (%) 28.4 22.9
Rms deviations
Bond length (A˚) 0.012 0.014
Bond angles () 1.38 1.13
Average B factor
Protein atoms (A˚2) 59.1 33.2
Solvent atoms (A˚2) 43.7 39.9
PDB code 2D1K 2D1L
Values in parentheses correspond to highest resolution shell.
a R merge=S(I  <I>)/SI; I and <I> are the intensity and the mean value of all the measurements of an individual reflection.
b R factor=SjFo  Fcj/S jFoj; Fo and Fc are the observed and calculated structure factors.
c R free; R factor calculated for a randomly selected subset of the reflections (5%) that were omitted during the refinement.RESULTS
Structure of the IMD of MIM
The crystal structure of the IMD of MIM (N-terminal
250 amino acids) was determined to 1.85 A˚ resolution,
by using the single anomalous dispersion method and
X-ray data collected from a Se-Met-substituted crystal
(Experimental Procedures and Table 1). The IMD forms
a dimer (Figure 1B). The structure is well defined in the
electron density map, except for three areas, which are
disordered: the last six amino acids of chain A, the last
eight amino acids of chain B, and amino acids Asp
155 to Ser 168 of chain B. The electron density map also
reveals three amino acids from the expression vector
(Ala-Gly-His) at the N-terminal ends of both chains.
Each chain is folded as an extended (135 A˚) antiparal-
lel three-helix bundle (Figure 1B). The two subunits in the
dimer are oriented opposite to one another and interact
extensively. Thus, the contact area between subunits isStructure 15, 145–2941 A˚2 (calculated with CCP4 program AreaIMOL, using
a 1.4 A˚ probe). The six helices that comprise the IMD
dimer form a twisted ellipsoid 183 A˚ in length and
30 A˚ in diameter (at the widest point). Despite extensive
contacts between adjacent helices, the IMD cannot be
classified as a coiled-coil structure. Indeed, an analysis
of the structure using the program Socket (Walshaw and
Woolfson, 2001) reveals that there exist short, scattered
regions of coiled-coil between pairs of helices, but not
a single region of the six-helix bundle displays the classi-
cal knobs-into-holes layer extending through all the
helices.
The dimer features a sizable 1396 A˚3 (calculated with
the program Swiss-PDB using a 1.4 A˚ probe) cavity in
the middle (Figure 1C). This cavity contains a number of
water molecules. Although the side chains that are di-
rected toward the cavity are predominantly hydrophobic,
a number of polar amino acids, including Thr 47, His 86,
Glu 213, and Glu 195, also point toward this cavity. These155, February 2007 ª2007 Elsevier Ltd All rights reserved 147
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Actin-Binding Domain of Missing-in-Metastasisamino acids are involved in interactions among them.
Thus, the Og of Thr 47 of one chain is hydrogen bonded
to the same atom from the other chain. Similarly, Glu
213 and Glu 195 of one chain form salt bridges with His
86 and Arg 69 from the other chain.
The structure of the IMD of IRSp53 has also been deter-
mined (Figure 1E) (Millard et al., 2005). The fact that this
structure could not be used as a molecular replacement
model to determine the current structure suggested from
the beginning that important differences were to be ex-
pected. Indeed, an alignment of the sequences based
on a superimposition of the structures reveals that the
IMDs of MIM and IRSp53 share only 19.3% sequence
identity, and although generally similar, the structures su-
perimpose with a relatively large rms deviation of 2.8 A˚.
The differences remain important within the core (or mid-
dle) region (rms deviation 1.64 A˚), defined as the region
where the two subunits of the dimer overlap (MIM residues
22–119 and 192–235). However, the two structures differ
more significantly toward the N- and C termini and the dis-
tal ends of the ellipsoid (corresponding to the loop be-
tween helices 2 and 3). These differences may be ascribed
mainly to increased flexibility in these regions, since the
identical molecules that form the IMD dimers also display
large rms deviations (2.0 A˚ for MIM and 1.5 A˚ for IRSp53).
The IMD of IRSp53 presents a short helix at the C ter-
minus (helix 4). In the structure of MIM’s IMD, only one turn
of this helix is observed for chain A (Figure 1E), whereas
the helix is fully missing in chain B, possibly due to local
disorder in the structure (Figure 1B). In contrast, the loop
Thr 234–Ser 242 preceding helix 4 (Figure 1D) is well de-
fined in the electron density map for both chains. The con-
formation of this loop is very similar between the two
chains of MIM, as well as between the two chains of
IRSp53. However, the conformation of the loop differs
quite significantly between the two proteins, which may
have functional implications. This loop forms a ‘‘flap’’
that covers the so-called signature sequence of the IMD
(Yamagishi et al., 2004) of the other molecule in the dimer
(Figure 1D). The signature sequence, EER[R/G]R (MIM
residues Glu 194–Arg198), is located within helix 3. MIM
presents a Gly at the fourth position of this motif, whereas
a bulkier residue (Arg 192) at this position in IRSp53 is di-
rected toward the flap loop and affects its conformation.
Another important difference is that a putative disulfide
bond in IRSp53 (Millard et al., 2005), between Cys 195
of the signature sequence and Cys 230 of the flap loop,
is missing in MIM, which lacks the latter Cys (correspond-
ing to Thr 234 in MIM).
Because the signature sequence forms part of a helix,
some of the charged amino acids in this sequence are
directed inward, while others are covered by the flap loop
(Figure 1D). As a result, MIM amino acids Glu 195, Arg 196,
and Arg 198 are all buried in the structure and make elec-
trostatic contacts with main chain atoms, as well as a salt
bridge between Glu 195 of one chain and Arg 69 of the
other chain. Charged amino acids are rarely buried, and
their occurrence typically points to important regions of
the structure. The occurrence of buried and charged148 Structure 15, 145–155, February 2007 ª2007 Elsevier Ltd Aside chains within the signature sequence and the interac-
tion with the ‘‘flap’’ loop, which connects the IMD to other
domains of the protein, suggest an important role for this
region of the IMD, possibly in the control or protein-protein
interactions involving the IMD.
Actin-Binding and -Bundling Activities
of the IMD of MIM
The IMD was originally described as an actin-binding
and -bundling domain (Yamagishi et al., 2004). However,
the ability of the IMD of human MIM to bundle actin in vitro
has lead to conflicting results, ranging from significant
bundling (Bompard et al., 2005) to weak (Yamagishi
et al., 2004) or no bundling activity (Gonzalez-Quevedo
et al., 2005). We decided to test the actin-binding
and -bundling activities of the IMD of mouse MIM, which
presents a four amino acid insert (154VDAQ157) (Mattila
et al., 2003) near what has been described as the actin-
binding site (Bompard et al., 2005; Millard et al., 2005).
F-actin binding by the IMD of mouse MIM was confirmed
using a high-speed cosedimentation experiment (Fig-
ure 2A and Experimental Procedures). A similar experi-
ment, carried out at varying IMD concentrations, resulted
in a Kd estimate of17 mM (Figure 2B). This value is similar
to that obtained for IRSp53 (5 mM) (Millard et al., 2005).
A cluster of basic amino acids at the distal ends of the
IMD dimer has been implicated in actin binding in
IRSp53 (Millard et al., 2005). Although mutations of indi-
vidual amino acids in this cluster had no effect in actin
binding, a construct where Lys residues 142, 143, 146,
and 147 were simultaneously mutated to Glu showed
somewhat reduced actin binding (10 mM versus 5 mM
for the wild-type IMD) (Millard et al., 2005). This result
was interpreted as evidence that the basic cluster is
involved in actin binding. However, the change in binding
affinity appears minor, in particular considering the effect
that a substitution of four positive charges by negative
charges could have on the general stability and electro-
static properties of the IMD dimer. The IMD of MIM also
presents positively charged clusters at the extremes of
the dimer (Figure 3A), featuring a total of ten positively
charged side chains in the region between Lys 131 and
Lys 153 (Figures 1B). The same group reported a similar
reduction in the actin binding affinity of MIM’s IMD when
Lys residues 149, 150, 152, and 153 in this cluster were
simultaneously replaced by Asp (Bompard et al., 2005).
Amino acids Ile 137, Leu 145, and Leu 147 (equivalent to
IRSp53 Leu 134, Lys 142, and Leu 144) are the only hydro-
phobic amino acids within the basic cluster of MIM
(Figure 1B). While Ile 137 is buried in the structure, Leu
147 is partially exposed and Leu 145 is fully exposed.
Given the general importance of hydrophobic amino acids
in protein-protein recognition (Jones and Thornton, 1996),
we decided to mutate these two Leu residues. Ten muta-
tions were generated, with both leucine residues being
replaced individually to Ala, Trp, Arg, and Glu, and simul-
taneously to Ala or Trp. These mutations were designed to
change the electrostatic character of the basic patch, as
well as to increase or reduce the size of the two exposedll rights reserved
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Actin-Binding Domain of Missing-in-MetastasisFigure 2. Testing the Actin Binding and Bundling Activities of the IMD of MIM
(A) Purified IMD (left panel) and high-speed F-actin binding assay (right panel). 10 mM aliquots of IMD were ultracentrifuged at 400,000 3 g in the
presence (+) and the absence () of 5 mM F-actin. Equal aliquots of supernatant (S) and pellet (P) were analyzed on a SDS-PAGE gel.
(B) Quantification of the F-actin binding affinity of the IMD. 2 mM F-actin aliquots were incubated with increasing amounts of IMD (0, 1, 2, 4, 6, 8, 10, 15,
and 20 mM) and analyzed on gel as in (A). Each point corresponds to the average densitometric reading of three independent experiments. The line
represents the best fit of the data to the Michaelis-Menten equation.
(C) High-speed cosedimentation analysis of IMD mutants. 10 mM aliquots of each mutant were incubated with 5 mM F-actin and analyzed on gel (upper
panel). The percentage of F-actin-bound IMD was calculated as the IMD fraction in pellet. Before each experiment the mutants were ultracentrifuged
at 400,0003 g to eliminate potential aggregates. The lower panel illustrates the percentage of bound (empty bars) versus unbound (black-filled bars)
mutants from three independent experiments.
(D) Low-speed analysis of the F-actin bundling activity of the IMD. 5 mM F-actin was centrifuged at 10,0003 g in the absence () and the presence (+)
of 10 mM wild-type IMD, and the supernatant (S) and pellet (P) were analyzed on gel (upper panel). F-actin stays in the supernatant, indicating the lack
of bundling activity. This result was confirmed by experiments carried out at increasing ratios IMD to F-actin (1, 2, 4, 6, 8, 10) (lower panel).hydrophobic side chains within this area. In addition, we
expected these mutations to alter the local conformation
of the basic patch, and thereby actin binding. To our
surprise, none of the mutations affected actin binding sig-
nificantly (Figure 2C). More importantly, the double muta-
tions did not contribute additively to a lesser actin-binding
efficiency. These results, which are quantitatively similar
to those obtained for IRSp53 (Millard et al., 2005), suggest
that the basic cluster is unlikely to form a major (or a single)
actin-binding site. Thus, although the actin-binding inter-
face appears to involve the region around the basic clus-
ter, other parts of the IMD are most likely also involved.
Note further that the structurally related BAR domain
(see below) presents a similar cluster of basic amino acids
at the distal ends of the dimer (Peter et al., 2004), and yetStructure 15, 145the BAR domain is not typically implicated in actin binding.
Instead, the basic cluster of the BAR domain binds nega-
tively charged phospholipid membranes (Peter et al.,
2004). Similarly, the basic cluster of the IMD has been
recently implicated in membrane binding (Suetsugu
et al., 2006).
We further tested the ability of the IMD of MIM to bundle
actin at physiological salt concentration. First, the quality
of F-actin for this experiment was checked using low-
speed sedimentation (10,000 3 g) and rotary-shadowing
electron microscopy, to guarantee that no bundles were
formed in the absence of the IMD. In contrast with two
previous reports (Bompard et al., 2005; Yamagishi et al.,
2004), we found that the IMD of MIM did not bundle F-
actin under any of the conditions tested (Figure 2D and–155, February 2007 ª2007 Elsevier Ltd All rights reserved 149
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Actin-Binding Domain of Missing-in-MetastasisExperimental Procedures). This result is in agreement,
however, with another report that a slightly longer MIM
construct (amino acids 1–277) showed markedly reduced
bundling activity compared to the full-length protein
(Gonzalez-Quevedo et al., 2005). The disagreement
between different laboratories concerning the bundling
activity of the IMD may have resulted from nonspecific
aggregation of the IMD at low ionic strengths, or the use
of F-actin preparations that appear to sediment even in
the absence of the IMD construct.
However, it could be also questioned whether the IMD
construct studied here is dimeric in solution. To answer
this question, we determined the molecular mass of the
IMD in solution using multi-angle light scattering com-
bined with particle separation by asymmetric field flow
fractionation (Figure S1 and legend; see the Supplemental
Data available with this article online). The molar mass of
the elution peak determined by this method was 56.7 ±
3.4 kDa, which is in excellent agreement with the expected
Figure 3. Structural and Functional Relationship between the
IMD and BAR Domains
(A) Electrostatic surface representation of the IMD dimer calculated
with the program APBS (Baker et al., 2001) and displayed with the pro-
gram PyMOL (http://www.pymol.org). Red and blue indicate nega-
tively and positively charged regions, respectively (red, 6 kTe1;
blue +6 kTe1). Note the positively charged and slightly convex sur-
face, which is thought to mediate the interactions with membranes
of the IMD (Suetsugu et al., 2006).
(B) Similar electrostatic representation of the BAR domain of amphi-
physin (Peter et al., 2004). The orientation is the same as in (A). Note
that the shape of the positively charged membrane binding surface
of the BAR domain is concave.
(C) Superimposition of the structures of the IMD of MIM (blue, yellow)
with that of the BAR domain of arfaptin complexed with Rac (Tarricone
et al., 2001) (gray). The orientation is the same as in (A) and (B). The two
folds have different curvatures, but superimpose well in the middle
section where the dimers overlap, suggesting that this region may
also mediate the binding of Rac in MIM and IRSp53.150 Structure 15, 145–155, February 2007 ª2007 Elsevier Ltd Atheoretical mass of the dimer (56.3 kDa). Combined, the
lack of bundling activity and the finding that the IMD is a di-
mer in solution would suggest that the actin binding sur-
face of the IMD spans over the two subunits of the dimer.
Structure of the WH2 of MIM Complexed with Actin
MIM presents a second actin-binding site at the C termi-
nus, consisting of a WH2 domain (Mattila et al., 2003).
We made a synthetic peptide corresponding to this
WH2, comprising amino acids Asp 724 to the C terminus
(Ser 755) of human MIM. With the exception of the first
two amino acids, which display conservative mutations,
this sequence is identical to that of mouse MIM (Figure 4A).
The crystal structure of this WH2 (Figure 4B) was deter-
mined as a ternary complex with actin-DNase I. DNase I,
which was necessary in order to prevent actin polymeriza-
tion during crystallization, does not appear to have a signif-
icant effect on the actin-binding affinity of WH2 (Chereau
et al., 2005), and makes no contacts with the WH2 peptide
in the current structure. However, the last two amino acids
of the peptide (Phe 754 and Ser 755) are disordered in the
structure, and we cannot distinguish whether this is due to
a local effect of DNase I, or that these amino acids do not
normally interact with actin and therefore become disor-
dered. Also disordered in the structure is the first amino
acid of the WH2 peptide, which does not appear to be im-
portant for actin binding, since the interactions with actin
start after residue Gly 728 of the WH2 peptide.
The structure of the WH2 of MIM can be conceptually
subdivided into two parts, an N-terminal amphiphilic helix,
comprising amino acids Gly 728 to Gly 738, and a C-termi-
nal extended region from Val 739 to Arg 753 (Figure 4B).
As previously shown (Chereau et al., 2005), the most im-
portant contribution to the interaction with actin comes
from the N-terminal helix that binds in the hydrophobic
cleft between actin subdomains 1 and 3. In the current
structure, amino acids Met 731, Leu 732, and Ile 735, on
the hydrophobic side of this helix, are embedded within
the hydrophobic cleft in actin (Figure 4B). The extended
portion of the WH2 of MIM follows a path alongside the ac-
tin surface, climbing to the top of actin subdomains 2 and
4. Amino acids Val 739 and Leu 741 within this region bind
in a hydrophobic pocket on the actin surface formed by
amino acids Ile 341, Ile 345, and Leu 349. Residue Leu
741 of the WH2 peptide forms part of the canonical
LKKT sequence, found in other actin-binding proteins,
such as thymosin b4 (Paunola et al., 2002) and the linker
region between gelsolin domains 1 and 2 (Irobi et al.,
2003). Interestingly, the two Lys residues of this canonical
sequence bind atop actin residues Asp 24 and Asp 25, but
interact with actin only via main chain atoms. Thus, the
main-chain nitrogen and oxygen atoms of Lys 742 are
hydrogen bonded to the oxygen and nitrogen atoms of
actin residues Gly 23 and Asp 25, respectively. The other
important element of the interaction for this part of the
WH2 peptide involves the segment Thr 746 to Arg 749,
which is incorporated as an additional b strand into
a b sheet in actin subdomain 1 (running parallel to actin
b strand Arg 28 to Phe 31). Finally, Arg 749 of the WH2ll rights reserved
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Actin-Binding Domain of Missing-in-MetastasisFigure 4. The WASP-Homology Domain 2 of MIM and IRSp53
(A) Comparison of a classical WH2 (represented by WASP, Wiskott-Aldrich syndrome protein) with the WH2s of MIM, ABBA, and IRSp53. Red, blue,
green, and yellow correspond to negatively charged, positively charged, hydrophobic, and small (Thr, Val, Ser, Ala) conserved amino acids, respec-
tively. The diagram above the sequences represents a secondary structure assignment based on the structure determined here (cylinder, a helix;
arrow, b strand). Accession numbers are as in Figure 1, and WASP_HUMAN, P42768. Red arrows point to noncanonical amino acids present in
the WH2 of IRSp53.
(B) Structure of the WH2 of MIM (red ribbon) bound to actin (gray surface). Numbers 1–4 indicate actin’s four subdomains. The side chains of some of
the amino acids involved in interactions with actin are shown (green, hydrophobic; blue, positively charged).
(C) Binding of the WH2 of IRSp53 to actin measured by ITC. The upper graph corresponds to the heat evolved upon repeated 10 ml injections of
a 100 mM solution of the WH2 peptide into a 10 mM solution of actin in G buffer. The lower graph shows the binding isotherm produced by integration
of the heat for each injection. The line represents a nonlinear least squares fit to the data using a single-site binding model. The following thermody-
namic parameters were determined from the fitting: dissociation constant Kd = 0.28 ± 0.04 mM; molar enthalpy DH = 7.2 ± 0.1 kcal.mol1; and
stoichiometry n = 0.9.peptide forms a salt bridge with actin residue Glu 93. The
remaining portion of WH2 extends across the cleft be-
tween actin subdomains 2 and 4, and appears to interact
only weakly with actin, which is consistent with the limited
contribution of this portion of WH2 to the actin binding
affinity (Chereau et al., 2005).
An Alternatively Spliced WH2 at the C Terminus
of IRSp53
IRSp53 is another actin cytoskeleton adaptor protein,
which like MIM presents an N-terminal IMD. Six isoforms
of IRSp53 have been identified. In addition to the IMD,
all six isoforms present identical CRIB, SH3, and WW pro-
tein-protein interaction modules. The differences between
isoforms occur at the C termini. Two of the isoforms pres-
ent a C-terminal extension consisting of a PDZ binding
sequence (Soltau et al., 2004), another two present
WH2-related extensions, and the remaining two appear
to have no functionally identifiable extensions. The WH2
of IRSp53 is unusual (Figure 4A). While the C-terminalStructure 15, 145–portion of this WH2 is nearly identical to that of MIM, the
N-terminal helix, known to play a critical role in actin bind-
ing (Chereau et al., 2005), has a noncanonical sequence.
Indeed, the periodicity of hydrophobic amino acids in
the segment corresponding to the helix is altered, and
there are conserved Pro and Gly residues in this region,
which could prevent the formation of a helix. In addition,
one of the Lys residues in the canonical LKKT sequence
is replaced by Pro in IRSp53 (Figure 4A). Taken together,
these observations raised doubts about the capacity of
this WH2 to bind actin. We decided to study the binding
of this WH2 to actin using ITC (Figure 4C). A peptide cor-
responding to the WH2 of human IRSp53 isoform 2, amino
acids Gly 506 to Ser 534, was synthesized (Figure 4A). The
actin-binding affinity of this peptide (Kd = 0.28 mM) was
found to be surprisingly similar to that measured previ-
ously by us under identical conditions for the WH2 of
MIM (Kd = 0.23 mM) (Chereau et al., 2005). Therefore, we
conclude that, like MIM, certain isoforms of IRSp53 pres-
ent two independent actin-binding domains at the N- and155, February 2007 ª2007 Elsevier Ltd All rights reserved 151
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central region featuring various protein-protein interaction
modules.
DISCUSSION
The IMD of MIM is an all a-helical structure, which dimer-
izes to form a twisted ellipsoid 183 A˚ in length, with
a large cavity in the middle (Figure 1). Despite low
sequence similarity, the structures of the IMDs of MIM
and IRSp53 (Millard et al., 2005) are generally similar.
The loop following helix 3 of MIM’s IMD forms a ‘‘flap’’
that covers the so-called ‘‘signature sequence’’ of the
IMD, a conserved and charged sequence that is conspic-
uously buried in the structure (Figure 1D).
While we were able to confirm that the IMD binds F-
actin with 17 mM affinity (Figures 2A and 2B), we found
that the symmetric patches of basic amino acids at the
distal ends of the dimer (Figure 3A) play only a limited
role in this interaction (Figure 2C). Furthermore, the IMD
is also a dimer in solution (Figure S1), but it does not bun-
dle actin (Figure 2D), as would have been expected if the
symmetric ends of the dimer were solely responsible for
actin binding. If, as previously suggested (Yamagishi
et al., 2004), MIM is an actin-bundling protein, this function
may require other parts of the molecule that lie outside the
IMD. Gonzalez-Quevedo et al. (2005) reached a similar
conclusion by studying various fragments of MIM. They
showed that most of the bundling activity could be
restored by a construct comprising amino acids 1–408
of MIM. Another possibility is that bundling is regulated
(or potentiated) in vivo by still unknown factors.
The IMD of IRSp53 interacts with Rac, possibly func-
tioning as an intermediate for the activation of WAVE,
which is recruited by the SH3 domain of IRSp53 (Miki
et al., 2000). Similarly, the IMD of MIM has been shown
to bind and activate Rac, suggesting that MIM could link
Rac to effector proteins involved in lamellipodia formation,
such as WAVE (Bompard et al., 2005). The structural basis
for the Rac-IMD interaction is unknown. Interestingly, the
structure of the IMD resembles that of the BAR domain,
which also binds small GTPases (Habermann, 2004).
The crystal structures of various BAR-domain proteins,
including arfaptin (Tarricone et al., 2001), amphiphysin
(Peter et al., 2004) and endophilin (Weissenhorn, 2005),
have been determined. Although the BAR domain is
curved and the IMD is relatively straight, the two folds
superimpose remarkably well in the middle section, where
the two subunits that conform these two domains overlap
(Figure 3C). It is via this well-overlapping middle section
that the binding of small GTPases appears to take place.
Indeed, the structure of arfaptin was also determined
bound to Rac (Tarricone et al., 2001). One molecule of
Rac sits at the midpoint of the arfaptin BAR dimer. It is
likely that the IMDs of MIM and IRSp53 bind Rac in a sim-
ilar fashion, as illustrated by a superimposition of the
structures of MIM and arfaptin-Rac (Figure 3C). Note,
however, that this superimposition does not represent
an accurate model of the interaction, since there is no152 Structure 15, 145–155, February 2007 ª2007 Elsevier Ltdobvious sequence similarity between the IMD and BAR
domains and local changes are likely.
The binding of Rac and actin by the IMD of MIM appear
to be mutually exclusive (Bompard et al., 2005). Although
this study did not determine the total extent of the actin-
binding interface, the lack of bundling activity (Figure 2D)
and the fact that the distal ends of the IMD dimer do not
constitute a major actin-binding site (Figure 2C) would
suggest that the middle section of the IMD dimer also
participates in actin binding. As suggested by the analogy
with the BAR domain, the binding of Rac may also involve
the middle section of the IMD dimer (Figure 3C), possibly
explaining why actin and Rac bind in a mutually exclusive
manner.
We have stressed here the striking resemblance
between the IMD and BAR folds, including their shared
ability to bind small GTPases. In addition, both domains
present similar clusters of positively charged amino acids
(Figures 3A and 3B), which in the BAR domain coincide
with the concave surface of the dimer and are involved
in phospholipid membrane binding (Peter et al., 2004).
The most noticeable difference between the two folds is
that the IMD forms relatively straight dimers (Millard
et al., 2005), whereas the BAR domain forms curved,
‘‘banana-shaped’’ dimers (Peter et al., 2004; Tarricone
et al., 2001; Weissenhorn, 2005). However, the curvature
of the BAR domain varies from protein to protein (arfaptin >
amphiphysin > endophilin), which may facilitate the bind-
ing to membranes with different curvatures. The IMD was
discovered independently and due to the lack of se-
quence similarity was not originally considered a member
of the BAR domain family (Yamagishi et al., 2004). A com-
parison of the structures of the IMD and BAR domains
would now suggest that the two domains are not only
structurally but also functionally related to each other (Fig-
ure 3). Indeed, it was recently reported that, like the BAR
domain, the IMD also binds membranes and that this func-
tion is mediated by the clusters of basic amino acids at
the distal ends of the dimer (Suetsugu et al., 2006; P. Lap-
palainen, personal communication). Interestingly, the
directionality of membrane deformation by the IMD (out-
ward) was found to be opposite to that produced by the
BAR domain (inward). The structures may provide an ex-
planation for this observation, because the concave and
positively charged surface implicated in membrane bind-
ing in the BAR domain adopts a somewhat convex shape
in the IMD (Figure 3). Therefore, the evidence to date sug-
gests that the IMD is a multifunctional module, linking the
actin cytoskeleton to the formation of membrane protru-
sions by direct interactions with both F-actin and mem-
branes, all under the control of the small GTPase Rac.
The WH2 of MIM interacts with all four subdomains of
actin (Figure 4B). It consists of an N-terminal amphiphilic
helix that binds in the cleft between actin subdomains 1
and 3 and a C-terminal extended region that binds along
the actin surface and the nucleotide cleft, reaching the top
of actin subdomains 2 and 4. Note that the end of this WH2
coincides with the C terminus of the MIM protein. The
prototypical WH2 found among WASP-family proteinsAll rights reserved
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interactions with actin after the LKKT sequence (Chereau
et al., 2005).
We demonstrated here that certain isoforms of IRSp53
present a C-terminal WH2 that binds actin with similar
affinity to that of the WH2 of MIM, further extending the
relationship between these two actin-cytoskeleton scaf-
folding proteins. WH2 is the smallest actin-binding motif
known. Based on their sequences and structures, we
have identified two types of WH2s: long and short
(Chereau et al., 2005). Short WH2s consist solely of the
N-terminal helix and the LKKT-related sequence (for
example, WASP’s WH2; Figure 4A). Long WH2s present
an additional10 amino acids at the C terminus. The extra
amino acids of long WH2s share sequence similarity with
Tb4 and make similar contacts with actin (Irobi et al.,
2004), supporting a previously proposed relationship
between the WH2 and Tb families (Paunola et al., 2002).
However, it remains unclear whether the extra amino
acids of long WH2s play any specific role, since they do
not seem to contribute significantly to the actin binding
affinity nor the nucleotide exchange inhibition by actin
(Chereau et al., 2005).
What is the role of WH2 in MIM and IRSp53? WH2 could
serve two possible functions: recruit actin monomers, or
recruit a protein to a specific actin cytoskeletal network.
Actin filament nucleation and elongation factors, including
WASP, Ena/VASP and spire, form the main group of WH2-
containing proteins. These proteins present short WH2s,
typically positioned C-terminal to Pro-rich sequences
(Figure 4A). In WASP, WH2 is followed by the central (or
C) region that binds one of the subunits of Arp2/3 com-
plex, whereas, in VASP, WH2 is known as the G-actin
binding domain (GAB) and is followed by the F-actin bind-
ing domain (FAB). The C region of WASP and the FAB
domain of VASP are related to each other, and both
constitute specialized forms of WH2 (Chereau and
Dominguez, 2006). Spire, on the other hand, contains
four WH2s in tandem (Quinlan et al., 2005). We have pro-
posed that in these proteins WH2 becomes involved in
nucleation and elongation by bridging actin subunits along
a single filament strand and by mediating the incorpora-
tion of profilin-actin at the barbed end of growing filaments
(Chereau and Dominguez, 2006; Chereau et al., 2005). So
far, we have identified long WH2s in actobindin, WIP, MIM
(Chereau et al., 2005), and now in IRSp53. It appears that,
in MIM and IRSp53, WH2 occurs within a different domain
organization than in most cytoskeletal proteins (Figure 4A).
Thus, in MIM and IRSp53, WH2 is found in isolation at the
C-terminal end; i.e. not immediately preceded by Pro-rich
sequences nor followed by other WH2s (or WH2-related
sequences). Unlike the actin monomer-trapping molecule
Tb4 and the nucleation-elongation factors described
above, MIM and IRSp53 function as scaffolding proteins.
It is therefore likely that WH2 helps recruit MIM and
IRSp53, as well as their multiple binding partners, to
specific cytoskeletal networks. Consistent with this idea,
images of cells overexpressing full-length MIM show a
significant loss of stress fibers (Gonzalez-Quevedo et al.,Structure 15, 145–12005; Mattila et al., 2003; Woodings et al., 2003), but
this effect appears diminished for MIM constructs lacking
the WH2 region (Bompard et al., 2005; Gonzalez-Quevedo
et al., 2005).
What is the spatial relationship between the IMD and
WH2 domains? Hydrophobic cluster analysis (Callebaut
et al., 1997) suggests that the region sandwiched in
between the IMD and WH2 of MIM is mostly unstructured,
with only two segments with predicted globular or induc-
ible folding (Figure S2). Given these characteristics and
the antiparallel organization of the IMD dimer, the two
WH2s could be located far apart from each other in the
protein, which would imply a lack of communication
between them. More likely, however, the various domains
of MIM and IRSp53 fold back into a more compact struc-
ture, possibly mediated by autoregulatory interactions
involving the IMD and other parts of the molecule.
EXPERIMENTAL PROCEDURES
Preparation of Proteins and Peptides
The cDNA encoding for full-length mouse MIM was purchased from
ATCC. Amino acids 1–250, corresponding to MIM’s IMD, were ampli-
fied by PCR and inserted into vector pTYB12 (New England Biolabs).
This vector comprises a chitin affinity purification tag and an intein
self-cleavage domain. IMD mutants (Leu 145 to Ala, Trp, Asp, Arg;
Leu 147 to Ala, Trp, Asp, Arg; and the double mutants Leu 145 and
Leu 147 to Ala; Leu 145 and Leu 147 to Trp) were generated using
the QuikChange Site-Directed Mutagenesis Kit (Stratagene).
BL21(DE3) cells (Invitrogen) were transformed with the various IMD
constructs and grown in LB medium at 37C until the OD at 600 nm
reached a value of 0.8. Expression was induced by addition of 1 mM
isopropylthio-b-D-galactoside (IPTG) and carried out overnight at
20C. Cells were harvested by centrifugation and resuspended in chi-
tin-affinity-column equilibration buffer (20 mM Tris [pH 7.5], 500 mM
NaCl, 1 mM EDTA, 100 mM PMSF), followed by standard purification
on a chitin affinity column at 4C (New England Biolabs manual). The
proteins were eluted from this column following DTT-induced self-
cleavage of the intein. The proteins were then dialyzed against
20 mM Tris (pH 7.5), 50 mM NaCl, and 1 mM DTT and purified to
homogeneity on a MonoQ column (Pharmacia). A Se-Met-substituted
IMD protein was obtained following a similar procedure by growing
cells in M9 media, supplemented with 70 mg/ml Se-Met. Actin was
prepared from rabbit muscle as described (Graceffa and Dominguez,
2003). Ultra-pure-grade bovine pancreatic DNase I was purchased
from BioWorld. WH2 domains, corresponding to human MIM724–755
and human IRSp53506–534, were synthesized on an ABI431 peptide
synthesizer and purified by HPLC. The concentrations of the peptides
were determined by amino acid analysis (Dana-Farber Cancer
Institute, Boston, MA).
F-Actin-Binding Assay
For this experiment actin underwent additional purification through
a gel filtration Sephacryl S300HR column (Pharmacia). Actin in G buffer
(2 mM Tris [pH 7.4], 0.2 mM CaCl2, 0.2 mM ATP, 1 mM DTT, 1 mM
NaN3) was polymerized by addition of 100 mM KCl, 2 mM MgCl2,
and 2 mM EGTA (F buffer). IMD and IMD mutants were dialyzed against
the same F buffer and centrifuged at 400,0003 g for 30 min before the
experiments, to remove potential aggregates. 10 mM IMD (or IMD mu-
tants) was mixed with 5 mM F-actin on ice and incubated for 30 min.
The protein mixtures were then centrifuged at 400,000 3 g for
30 min. Equal volumes of supernatant and pellet were analyzed on
a 15% SDS-PAGE gel. A quantification of the F-actin binding affinity
was obtained by adding increasing amounts of IMD (0, 1, 2, 4, 6, 8,
10, 15, and 20 mM) to 2 mM F-actin and analyzed as described above.55, February 2007 ª2007 Elsevier Ltd All rights reserved 153
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tion, and the intensities of the bands were quantified using the program
ImageJ version 1.34S (http://rsb.info.nih.gov/).
F-Actin-Bundling Assay
Actin was purified and polymerized as described above. Before each
bundling experiment, both F-actin and the IMD were centrifuged for
30 min at 10,000 and 400,000 3 g, respectively. Note that this step
is important in order to remove potential high molecular weight aggre-
gates. F-actin samples were then visualized on a Philips EM 300 elec-
tron microscope to ensure that actin bundles were not present prior to
the addition of the IMD. 10 mM IMD was then mixed with 5 mM F-actin
and incubated for 1 hr at room temperature. Next, the mixture was
centrifuged at low speed (10,0003 g) for 30 min at room temperature.
Supernatant and pellet were analyzed by SDS-PAGE gel as described
above. A quantitative bundling assay was done in a similar way by add-
ing increasing amounts of IMD (1, 2, 4, 6, 8, and 10 mM) to 1 mM F-actin.
Crystallization, Data Collection and Structure Determination
Actin-DNase I complex at a 1:1 molar ratio was mixed with MIM’s WH2
domain peptide at 1.5 molar excess. The ternary complex was then di-
alyzed against G-buffer (2 mM Tris [pH 7.5], 0.2 mM CaCl2, 0.2 mM
ATP, 1 mM NaN3) and concentrated to 10 mg/ml using a Centricon
device (Millipore). The complex was crystallized at 20C, using the
hanging drop vapor diffusion method. The 2 ml hanging drops con-
sisted of a 1:1 (v/v) mixture of protein solution and a well solution con-
taining 13%–14% PEG 3350, 50 mM Na cacodylate (pH 6.8–7.2), and
100 mM Na-formate. Before crystallization MIM’s IMD was dialyzed
against 20 mM Tris (pH 7.4), 50 mM NaCl, and 5 mM DTT and concen-
trated to 20 mg/ml. Crystals were obtained at 4C in 0.1 M Tris
(pH 7.4), 0.2 M LiCl, and 16% PEG 2000 MME. The crystals were
flash-frozen in propane, using 25% glycerol as cryoprotectant. X-ray
data sets were collected at the BioCARS beamlines 14-BM-D (IMD)
and 14-BM-C (actin-WH2) at the Advance Photon Source (Argonne,
IL). The data sets were indexed and scaled with program HKL-2000
(HKL Research, Inc.). The structure of the actin-WH2 complex was
determined by molecular replacement using CCP4 program AMoRe
and the structure of WIP-actin-DNase I as a search model (Chereau
et al., 2005). Model building and refinement were done with the
program Coot (Emsley and Cowtan, 2004) and CCP4 program Refmac
(Table 1).
The structure of the IMD was determined from the anomalous signal
of a Se-Met-substituted crystal, using the single anomalous dispersion
(SAD) method and data collected to 2.1 A˚ resolution at the absorption
peak wavelength of the Se atoms (Table 1). The positions of 11 out of
18 Se atoms in the structure were found with the program SnB (Weeks
and Miller, 1999). These positions were then refined and phases were
calculated with the program Solve (Terwilliger and Berendzen, 1999).
About 70% of the model was built automatically with the program
ARP/wARP (Morris et al., 2003) and using a 1.85 A˚ resolution X-ray
dataset collected from the same Se-Met substituted crystal. Further
model building and refinement were carried out with the program
Coot (Emsley and Cowtan, 2004) and CCP4 program Refmac. Data
collection and refinement statistics are given in Table 1.
Isothermal Titration Calorimetry
These measurements were done using a VP-ITC (MicroCal, Northamp-
ton, MA). To determine DH and Ka of WH2-actin association, the WH2
peptide of IRSp53 at a concentration of 100 mM was titrated, in 10 ml
injections, into 1.44 ml of 10 mM actin in G buffer at 25C. The duration
of each injection was 10 s, with an interval of 3 min between injections.
The heat of binding was corrected for the small exothermic heat of
injection, determined by injecting WH2 peptides into buffer. Data
were analyzed using MicroCal’s Origin program.
Supplemental Data
Supplemental Data include two figures and are available at http://
www.structure.org/cgi/content/full/15/2/145/DC1/.154 Structure 15, 145–155, February 2007 ª2007 Elsevier Ltd AlACKNOWLEDGMENTS
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